Diagnostics for the Real World (DRW)

Diagnostics for the Real World (DRW) is a biotechnology company founded in 2003, originating from the University of Cambridge. The company focuses on developing and commercializing innovative diagnostic technologies tailored for resource-limited and real-world clinical settings, particularly in developing countries. DRW specializes in point-of-care molecular diagnostics, enabling rapid and reliable testing of infectious diseases directly at the site of patient care. Its flagship technology, the SAMBA platform, is designed for challenging environments, requiring no complex laboratory infrastructure. The company offers a range of products, including rapid tests for Chlamydia and HIV, as well as multiplex respiratory virus tests that detect multiple pathogens from a single sample. DRW collaborates with international organizations to implement its technologies, aiming to improve healthcare outcomes in areas with limited access to diagnostic resources.

• Employees 39